20/20 Biolabs (AIDX) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $0.26, -6.93% vs the prior close of $0.28.
- Volume 188.18K shares, 2.1x its 50-day average (heavy).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
AIDX slides 6.9% to $0.26, a 6-month low on 2.1x normal volume. Closed at $0.26, -6.93% vs the prior close of $0.28. Day range $0.26–$0.28, opened at $0.28.
AIDX daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — AIDX slides 6.9% to $0.26, a 6-month low on 2.1x normal volume
- Closed at $0.26, -6.93% vs the prior close of $0.28. Day range $0.26–$0.28, opened at $0.28.
- Volume was 188.18K shares, 2.1x its 50-day average of 87.86K — unusually heavy trading.
- Price is -45.1% vs its 50-day average ($0.48).
- 52-week range $0.26–$50.00; today's close sits at 0% of that range, 99.5% below the 52-week high.
- That makes 6 straight losses.
Oct 15, 2026 — AIDX slides 9.7% to $0.28, a 6-month low on 3.3x normal volume
- Closed at $0.28, -9.68% vs the prior close of $0.31. Day range $0.27–$0.31, opened at $0.31.
- Volume was 274.30K shares, 3.3x its 50-day average of 83.79K — unusually heavy trading.
- Price is -41.5% vs its 50-day average ($0.48).
- 52-week range $0.27–$50.00; today's close sits at 0% of that range, 99.4% below the 52-week high.
- That makes 5 straight losses.
Oct 14, 2026 — AIDX slides 11.4% to $0.31, a 6-month low on 3.3x normal volume
- Closed at $0.31, -11.43% vs the prior close of $0.35. Day range $0.30–$0.36, opened at $0.35.
- Volume was 268.40K shares, 3.3x its 50-day average of 82.11K — unusually heavy trading.
- Price is -35.7% vs its 50-day average ($0.48).
- 52-week range $0.30–$50.00; today's close sits at 0% of that range, 99.4% below the 52-week high.
- That makes 4 straight losses.
Oct 13, 2026 — AIDX slides 5.4% to $0.35, 3 down days in a row
- Closed at $0.35, -5.41% vs the prior close of $0.37. Day range $0.35–$0.37, opened at $0.37.
- Volume was 81.70K shares, 1.0x its 50-day average of 82.87K.
- Price is -27.8% vs its 50-day average ($0.48).
- 52-week range $0.33–$50.00; today's close sits at 0% of that range, 99.3% below the 52-week high.
- That makes 3 straight losses.
Oct 12, 2026 — AIDX dips 2.6% to $0.37 on 2.3x normal volume
- Closed at $0.37, -2.63% vs the prior close of $0.38. Day range $0.36–$0.40, opened at $0.38.
- Volume was 181.60K shares, 2.3x its 50-day average of 80.53K — unusually heavy trading.
- Price is -24.0% vs its 50-day average ($0.49).
- 52-week range $0.33–$50.00; today's close sits at 0% of that range, 99.3% below the 52-week high.
Oct 9, 2026 — AIDX ends flat (+0.0%) to $0.38
- Closed at $0.38, +0.00% vs the prior close of $0.38. Day range $0.36–$0.39, opened at $0.37.
- Volume was 64.50K shares, 0.8x its 50-day average of 81.89K.
- Price is -22.1% vs its 50-day average ($0.49).
- 52-week range $0.33–$50.00; today's close sits at 0% of that range, 99.2% below the 52-week high.
Oct 8, 2026 — AIDX jumps 11.8% to $0.38 on 2.3x normal volume
- Closed at $0.38, +11.76% vs the prior close of $0.34. Day range $0.35–$0.40, opened at $0.36.
- Volume was 186.30K shares, 2.3x its 50-day average of 79.78K — unusually heavy trading.
- Price is -22.2% vs its 50-day average ($0.49).
- 52-week range $0.33–$50.00; today's close sits at 0% of that range, 99.2% below the 52-week high.
Oct 7, 2026 — AIDX dips 2.9% to $0.34, a 6-month low, 5 down days in a row
- Closed at $0.34, -2.86% vs the prior close of $0.35. Day range $0.34–$0.36, opened at $0.36.
- Volume was 76.40K shares, 0.9x its 50-day average of 80.81K.
- Price is -30.5% vs its 50-day average ($0.49).
- 52-week range $0.33–$50.00; today's close sits at 0% of that range, 99.3% below the 52-week high.
- That makes 5 straight losses.
Oct 6, 2026 — AIDX ends flat (+0.0%) to $0.35, 4 down days in a row
- Closed at $0.35, +0.00% vs the prior close of $0.35. Day range $0.34–$0.36, opened at $0.35.
- Volume was 68.90K shares, 0.8x its 50-day average of 82.26K.
- Price is -28.8% vs its 50-day average ($0.49).
- 52-week range $0.33–$50.00; today's close sits at 0% of that range, 99.3% below the 52-week high.
- That makes 4 straight losses.
Oct 5, 2026 — AIDX slides 7.9% to $0.35, a 6-month low, 3 down days in a row
- Closed at $0.35, -7.89% vs the prior close of $0.38. Day range $0.33–$0.40, opened at $0.40.
- Volume was 117.10K shares, 1.4x its 50-day average of 81.55K.
- Price is -29.1% vs its 50-day average ($0.49).
- 52-week range $0.33–$50.00; today's close sits at 0% of that range, 99.3% below the 52-week high.
- That makes 3 straight losses.
Oct 2, 2026 — AIDX slides 7.3% to $0.38, a 6-month low
- Closed at $0.38, -7.32% vs the prior close of $0.41. Day range $0.36–$0.43, opened at $0.41.
- Volume was 65.30K shares, 0.8x its 50-day average of 84.10K.
- Price is -23.5% vs its 50-day average ($0.50).
- 52-week range $0.36–$50.00; today's close sits at 0% of that range, 99.2% below the 52-week high.
AIDX latest news & SEC filings
Every SEC filing by or about AIDX in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 6, 2026 · Form PRE 14A — Preliminary proxy statement
Preliminary proxy statement
Sep 18, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Sep 10, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.01 — Stock exchange listing notice or transfer of listing.
Sep 2, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 19, 2026 · Form DEFA14A — Additional proxy materials
Additional proxy materials
Aug 19, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Aug 17, 2026 · Form 424B3 — Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 17, 2026 · Form 424B3 — Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 17, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 14, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $730.57K (prior year $535.06K) (+36.5% vs Jun 30, 2025)
- Net income: -$1.51M (prior year -$840.93K) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.26 (prior year -$0.17) (loss widened vs Jun 30, 2025)
Aug 5, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Jul 22, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 3.01 — Stock exchange listing notice or transfer of listing.
Jul 1, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Jun 23, 2026 · Form DEFA14A — Additional proxy materials
Additional proxy materials
Jun 23, 2026 · Form DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Things to know before you trade AIDX
- Last results release: Aug 17, 2026 (8-K Item 2.02). Previous ones: May 20, 2026, Apr 1, 2026. Based on that rhythm, the next report is likely around Nov 16, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 4.90% (largest 11.8%). That is a volatile stock.
- Liquidity: about 106.21K shares (≈$27.68K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.26 vs a range of $0.26–$50.00 (0% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Sep 18, 2026; 8-K Sep 10, 2026; 8-K Sep 2, 2026.
- Listing: Nasdaq · industry: Services-Testing Laboratories.
AIDX market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 0.28 | 0.28 | 0.26 | 0.26 | 188.18K |
| Oct 15, 2026 | 0.31 | 0.31 | 0.27 | 0.28 | 274.30K |
| Oct 14, 2026 | 0.35 | 0.36 | 0.30 | 0.31 | 268.40K |
| Oct 13, 2026 | 0.37 | 0.37 | 0.35 | 0.35 | 81.70K |
| Oct 12, 2026 | 0.38 | 0.40 | 0.36 | 0.37 | 181.60K |
| Oct 9, 2026 | 0.37 | 0.39 | 0.36 | 0.38 | 64.50K |
| Oct 8, 2026 | 0.36 | 0.40 | 0.35 | 0.38 | 186.30K |
| Oct 7, 2026 | 0.36 | 0.36 | 0.34 | 0.34 | 76.40K |
| Oct 6, 2026 | 0.35 | 0.36 | 0.34 | 0.35 | 68.90K |
| Oct 5, 2026 | 0.40 | 0.40 | 0.33 | 0.35 | 117.10K |
| Oct 2, 2026 | 0.41 | 0.43 | 0.36 | 0.38 | 65.30K |
| Oct 1, 2026 | 0.43 | 0.45 | 0.41 | 0.41 | 52.00K |
| Sep 30, 2026 | 0.44 | 0.47 | 0.41 | 0.44 | 44.20K |
| Sep 29, 2026 | 0.46 | 0.46 | 0.41 | 0.41 | 103.00K |
| Sep 28, 2026 | 0.43 | 0.43 | 0.40 | 0.41 | 41.30K |
| Sep 25, 2026 | 0.43 | 0.47 | 0.43 | 0.43 | 60.80K |
| Sep 24, 2026 | 0.43 | 0.43 | 0.40 | 0.42 | 81.00K |
| Sep 23, 2026 | 0.47 | 0.50 | 0.40 | 0.43 | 77.70K |
| Sep 22, 2026 | 0.47 | 0.50 | 0.46 | 0.47 | 33.40K |
| Sep 21, 2026 | 0.51 | 0.51 | 0.45 | 0.47 | 58.10K |
About 20/20 Biolabs
20/20 Biolabs (AIDX) is listed on the Nasdaq and classified by the SEC under “Services-Testing Laboratories”. Its business address is in ROCKVILLE, MD. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1139685.
AIDX board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Richard M Cohen | Director | Feb 23, 2026 |
| Jonathan M Cohen | Chief Executive Officer | Mar 4, 2026 |
| John G. Compton | Director | Feb 23, 2026 |
| Prasanth Reddy | Director | Feb 17, 2026 |
| John Woodson Rollins | Director | Feb 23, 2026 |
| Michael A. Ross | Director | Feb 23, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Ron Baker | Chief Business Officer | Feb 17, 2026 |
| Alan B. Bergman | Chief Financial Officer | Apr 6, 2026 |
| Jonathan M Cohen | Chief Executive Officer | Mar 4, 2026 |
| Michael Saul Lebowitz | Chief Scientific Officer | Feb 17, 2026 |
| Jiming Zhou | Chief Operating Officer | Apr 6, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
AIDX financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $2.05M | $-3.74M | -0.76 | $-1.92M |
| Dec 31, 2024 | $1.75M | $-5.55M | -1.16 | $-2.60M |
Latest balance sheet: total assets $6.12M, total liabilities $2.96M, cash $4.55M (as of Jun 30, 2026).
AIDX earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 17, 2026 | 8-K Item 2.02 (results) | $0.55 |
| May 20, 2026 | 8-K Item 2.02 (results) | $1.29 |
| Apr 1, 2026 | 8-K Item 2.02 (results) | $1.88 |
Related stocks · Services-Testing Laboratories
UL Solutions (ULS)Neogenomics (NEO)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on AIDX
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.